+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

South America Amniotic Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and End User

  • PDF Icon

    Report

  • 120 Pages
  • September 2022
  • The Insight Partners
  • ID: 5668513
UP TO OFF until Mar 31st 2024
The SAM amniotic products market is expected to grow from US$ 71.16 million in 2022 to US$ 111.62 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2022 to 2028.

According to a 2018 retrospective examination of Medicare users, 8.2 million persons suffered wounds that were infected or not. The cost of acute and chronic wound treatments was estimated to cost between US$ 28.1 billion and US$ 96.8 billion by Medicare. Surgical wounds were the most expensive, followed by diabetic foot ulcers, with outpatient wound care costs higher than inpatient wound care. Traumatic wounds are a significant clinical, social, and economic burden because of the rising healthcare expenditures, an aging population, identification of difficult-to-treat infection risks such as biofilms, and the global hazard of diabetes and obesity. Traumatic wounds are those that have not proceeded through the normal healing process and have been open for longer than a month. Traumatic wounds have a variety of causes, all of which place a strain on the healthcare system. Diabetic and obese patients are at a higher risk of getting chronic wounds. Most persons who have a long-term open wound also have additional serious health problems. Comorbidity refers to the existence of multiple chronic diseases at the same time. Comorbidities complicate chronic wounds, making it difficult to follow chronic wounds as a disease in and of itself. In comparison to the overall burden of chronic wounds as a health care concern, research funding dedicated to studying chronic wounds is disproportionately low. Wound healing using amniotic membrane grafts has some therapeutic potential. Early use of an amniotic membrane for ulcers, burns, and cutaneous injuries proved therapeutic. Therefore, an increasing number of traumatic wounds is boosting the amniotic product market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM amniotic products market . The SAM amniotic products market is expected to grow at a good CAGR during the forecast period.

SAM Amniotic Products Market Segmentation

The SAM amniotic products market is bifurcated based on type, application, end user and country.
  • Based on type, the market is segmented into amniotic membranes, and amniotic suspensions. The amniotic membranes segment dominated the market in 2022 and is expected to be fastest growing during forecast period.
  • Based on application, the market is segmented into wound care, orthopedics, ophthalmology, and other applications. The wound care segment dominated the market in 2022 and orthopedics segment is expected to be fastest growing during forecast period.
  • Based on end user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment dominated the market in 2022 and ambulatory surgical centers segment is expected to be fastest growing during forecast period.
  • Based on country, the SAM amniotic products market is segmented into the Brazil, Argentina, and Rest of SAM.
Integra LifeSciences; Katena Products. Inc.; MiMedx; NuVision Biotherapies Ltd; Organogenesis, Inc.; Sanuwave and Sanuwave Health, Inc.; Smith & Nephew; and Stryker are among the leading companies in the SAM amniotic products market.
Frequently Asked Questions about the South American Amniotic Products Market

What is the estimated value of the South American Amniotic Products Market?

The South American Amniotic Products Market was estimated to be valued at $71.16 Million in 2022.

What is the growth rate of the South American Amniotic Products Market?

The growth rate of the South American Amniotic Products Market is 7.8%, with an estimated value of $111.62 Million by 2028.

What is the forecasted size of the South American Amniotic Products Market?

The South American Amniotic Products Market is estimated to be worth $111.62 Million by 2028.

Who are the key companies in the South American Amniotic Products Market?

Key companies in the South American Amniotic Products Market include Integra LifeSciences, Katena Products. Inc., MiMedx, NuVision Biotherapies Ltd, Organogenesis, Inc., Sanuwave and Sanuwave Health, Inc., Smith & Nephew and Stryker.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Amniotic Products Market - By Type
1.3.2 SAM Amniotic Products Market - By Application
1.3.3 SAM Amniotic Products Market - By End User
1.3.4 SAM Amniotic Products Market - By Country
2. SAM Amniotic Products Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Amniotic Products Market - Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. Amniotic Products Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Burn Injuries
5.1.2 Increasing Number of Traumatic Wounds
5.2 Market Restraints
5.2.1 Complications and Limitations Associated with Use of Amniotic Membranes
5.3 Market Opportunities
5.3.1 Implementation of the 21st Century Cures Act
5.4 Future Trends
5.4.1 Increasing Demand for Stem Cell Research and Regenerative Medicine
5.5 Impact Analysis
6. Amniotic Products Market- SAM Analysis
6.1 SAM Amniotic Products Market Revenue Forecast and Analysis
6.1.1 Overview
7. SAM Amniotic Products Market Revenue and Forecast to 2028 - by Type
7.1 Overview
7.2 SAM Amniotic Products Market, by Type, 2022 & 2028 (%)
7.3 Amniotic Membranes
7.3.1 Overview
7.3.2 Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Cryopreserved Amniotic Membranes
7.3.2.1.1 Cryopreserved Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Dehydrated Amniotic Membranes
7.3.2.2.1 Dehydrated Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
7.4 Amniotic Suspensions
7.4.1 Overview
7.4.2 Amniotic Suspensions: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
8. SAM Amniotic Products Market Revenue and Forecast to 2028 - by Application
8.1 Overview
8.2 SAM Amniotic Products Market Share by Application - 2022 & 2028 (%)
8.3 Wound Care
8.3.1 Overview
8.3.2 Wound Care: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
8.4 Orthopedics
8.4.1 Overview
8.4.2 Orthopedics: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
8.5 Ophthalmology
8.5.1 Overview
8.5.2 Ophthalmology: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
8.6 Other Applications
8.6.1 Overview
8.6.2 Other Applications: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
9. SAM Amniotic Products Market Revenue and Forecast to 2028 - by End User
9.1 Overview
9.2 SAM Amniotic Products Market Share by End User - 2022 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)
10. SAM Amniotic Products Market Revenue and Forecast to 2028 - by Country
10.1 Overview
10.1.1 SAM: Amniotic Products Market - Revenue and Forecast to 2028 (USD Million)
10.1.2 SAM: Amniotic Products Market, By Type, 2019-2028 (USD Million)
10.1.2.1 SAM Amniotic Products Market in Amniotic Membranes, by Type- Revenue and Forecast to 2028 (USD Million)
10.1.3 SAM: Amniotic Products Market, By Application, 2019-2028 (USD Million)
10.1.4 SAM: Amniotic Products Market, by End User, 2019-2028 (USD Million)
10.1.5 SAM: Amniotic Products Market, by Country, 2022 & 2028 (%)
10.1.5.1 Brazil: Amniotic Products Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.1.1 Brazil: Amniotic Products Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.1.2 Brazil: Amniotic Products Market, By Type, 2019-2028 (USD Million)
10.1.5.1.2.1 Brazil Amniotic Products Market in Amniotic Membranes, by Type- Revenue and Forecast to 2028 (USD Million)
10.1.5.1.3 Brazil: Amniotic Products Market, By Application, 2019-2028 (USD Million)
10.1.5.1.4 Brazil: Amniotic Products Market, by End User, 2019-2028 (USD Million)
10.1.5.2 Argentina: Amniotic Products Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.2.1 Argentina: Amniotic Products Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.2.2 Argentina: ? Amniotic Products Market, By Type, 2019-2028 (USD Million)
10.1.5.2.2.1 Argentina Amniotic Products Market in Amniotic Membranes, by Type- Revenue and Forecast to 2028 (USD Million)
10.1.5.2.3 Argentina: Amniotic Products Market, By Application, 2019-2028 (USD Million)
10.1.5.2.4 Argentina: Amniotic Products Market, by End User, 2019-2028 (USD Million)
10.1.5.3 Rest of SAM: Amniotic Products Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.3.1 Rest of SAM: Amniotic Products Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.3.2 Rest of SAM: Amniotic Products Market, By Type, 2019-2028 (USD Million)
10.1.5.3.2.1 Rest of SAM Amniotic Products Market in Amniotic Membranes, by Type- Revenue and Forecast to 2028 (USD Million)
10.1.5.3.3 Rest of SAM: Amniotic Products Market, By Application, 2019-2028 (USD Million)
10.1.5.3.4 Rest of SAM: Amniotic Products Market, by End User, 2019-2028 (USD Million)
11. Amniotic Products Market-Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 MiMedx
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Smith & Nephew
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Integra LifeSciences
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Stryker
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Katena Products. Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 NuVision Biotherapies Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Organogenesis, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Sanuwave and Sanuwave Health, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Integra LifeSciences
  • Katena Products. Inc.
  • MiMedx
  • NuVision Biotherapies Ltd
  • Organogenesis, Inc.
  • Sanuwave and Sanuwave Health, Inc.
  • Smith & Nephew
  • Stryker